Japan Asthma Inhaler Device Market
Japan Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
Industry Developments
In recent months, the Japan Asthma Inhaler Device Market has seen several significant developments. Companies such as Pfizer and Merck have been focusing on expanding their product lines to include more advanced inhaler technologies, addressing the rising asthma prevalence in Japan. In July 2023, GlaxoSmithKline announced a strategic partnership with a local Japanese health technology firm to improve the accessibility of their inhaler devices in rural areas. Meanwhile, Boehringer Ingelheim has rolled out a new training program for healthcare professionals in Japan to enhance the understanding of optimal inhaler use among patients, which is crucial given Japan's aging population and the increasing burden of respiratory diseases. Additionally, in September 2023, AstraZeneca unveiled its innovative inhaler designed for easier handling, aiming to increase adherence rates among Japanese patients. The market is also witnessing a trend toward digital inhaler options, with companies like Teva Pharmaceutical Industries exploring digital health solutions to support asthmatic patients. These developments underscore a dynamic and competitive landscape in the Japan Asthma Inhaler Device Market, as companies aim to improve patient outcomes amidst growing health concerns.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 46.2(USD Million) |
| MARKET SIZE 2024 | 50.82(USD Million) |
| MARKET SIZE 2035 | 120.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.124% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, Merck, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, Mylan, Novartis, Sanofi, Hikma Pharmaceuticals, Otsuka Pharmaceutical, Sandoz, Kyorin Pharmaceutical, Teva Pharmaceutical Industries, AstraZeneca |
| SEGMENTS COVERED | Type, Mode of Operation, End User |
| KEY MARKET OPPORTUNITIES | Increasing asthma prevalence, Emerging digital inhaler technology, Growing demand for portable devices, Rising focus on personalized medicine, Expansion of telehealth services |
| KEY MARKET DYNAMICS | growing asthma prevalence, increasing healthcare expenditure, technological advancements in inhalers, shift towards personalized medicine, rising demand for portable devices |
| COUNTRIES COVERED | Japan |
FAQs
What is the projected market size of the Japan Asthma Inhaler Device Market in 2024 and 2035?
The Japan Asthma Inhaler Device Market is expected to be valued at 50.82 million USD in 2024 and grow to 120.0 million USD by 2035.
What is the expected compound annual growth rate (CAGR) of the Japan Asthma Inhaler Device Market from 2025 to 2035?
The Japan Asthma Inhaler Device Market is projected to have a CAGR of 8.124% from 2025 to 2035.
Which segment of the Japan Asthma Inhaler Device Market is expected to dominate by 2035?
By 2035, Metered Dose Inhalers are expected to dominate the market, projected to reach 50.0 million USD.
What are the expected market values for Dry Powder Inhalers by 2024 and 2035?
Dry Powder Inhalers are anticipated to be valued at 20.0 million USD in 2024 and 45.0 million USD in 2035.
Who are the major competitors in the Japan Asthma Inhaler Device Market?
Key players in the market include Pfizer, Merck, GlaxoSmithKline, Roche, and AstraZeneca among others.
What is the market value of Soft Mist Inhalers in 2024 and their projection for 2035?
Soft Mist Inhalers are projected to be valued at 9.82 million USD in 2024, increasing to 25.0 million USD by 2035.
What key applications drive growth in the Japan Asthma Inhaler Device Market?
The key applications driving growth include the management and treatment of asthma as well as chronic obstructive pulmonary disease (COPD).
How does the growth of the Japan Asthma Inhaler Device Market reflect the trends in asthma care?
The growth reflects increasing awareness of asthma management and advancements in inhalation technology applicable in patient care.
What challenges are faced by the Japan Asthma Inhaler Device Market?
Challenges include strict regulatory requirements and the need for continuous innovation to meet patient needs and expectations.
What are the potential opportunities for growth in the Japan Asthma Inhaler Device Market?
Potential opportunities include the increasing prevalence of asthma in Japan and the growing demand for advanced inhalation devices.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment